DMPS can reverse the features of severe mercury vapor-induced neurological damage

Abstract

We recommend that the administration of 2,3-dimercapto-1-propanesulfonate should be considered in symptomatic patients who have been exposed to mercury vapor and who have supporting analytical confirmation of the diagnosis.